Skip to main content
. 2020 Sep 4;10(9):91. doi: 10.1038/s41408-020-00357-4

Fig. 2. Overall survival.

Fig. 2

aUpper limit of the 95.4% CI is <1 when calculated to 3 decimal places: HR, 0.820; 95.4% CI, 0.676–0.995; P = 0.0408. CI confidence interval, ERd elotuzumab plus lenalidomide and dexamethasone, HR hazard ratio, OS overall survival, Rd lenalidomide and dexamethasone.